Lifitegrast
2 NDCs across 2 manufacturers|0 Generic,2 Brand
Lifitegrast is used to treat dry eye syndromes, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 11, 2016, and the first generic was approved Aug 4, 2023. In 2024, Medicare Part D spent $505 million on Lifitegrast across 477,000 claims for 166,000 beneficiaries.
Lifitegrast is available as 2 NDCs from 2 manufacturers (0 generic, 2 brand), with NADAC prices from $11.83 to $11.83 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
2
competing in market
Price Spread
$11.83 – $11.83
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing LIFITEGRAST
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XIIDRA 5% EYE DROPS | $11.8311 per EA | 0.00% |
XIIDRA 5% EYE DROPS | $11.8311 per EA | 0.00% |
Frequently Asked Questions
What is Lifitegrast used to treat?
Lifitegrast is used to treat dry eye syndromes, per the National Library of Medicine's MED-RT classification.
When did Lifitegrast become available as a generic?
FDA approved the first generic Lifitegrast (ANDA) on Aug 4, 2023.
How much does Medicare spend on Lifitegrast?
In 2024, Medicare Part D spent $505 million on Lifitegrast across 477,000 claims for 166,000 beneficiaries.
How many Lifitegrast products are on the market?
The Lifitegrast drug market contains 2 NDCs from 2 manufacturers — 0 generic and 2 brand products.
What is the price range for Lifitegrast?
NADAC reference prices for Lifitegrast range from $11.8311 to $11.8311 per EA.
Which manufacturers make Lifitegrast?
2 manufacturers list Lifitegrast in NADAC. Ranked by number of NDCs, the largest are Novartis Pharmaceuticals Corporation (1), Bausch & Lomb Incorporated (1).
How has the price of Lifitegrast changed recently?
Over the past 7 days, 0 Lifitegrast NDCs rose and 0 fell, with a market-wide average change of +0.0%.